Organotechnetium Compounds
"Organotechnetium Compounds" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Organic compounds that contain technetium as an integral part of the molecule. These compounds are often used as radionuclide imaging agents.
| Descriptor ID |
D015609
|
| MeSH Number(s) |
D02.691.825
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Organotechnetium Compounds".
Below are MeSH descriptors whose meaning is more specific than "Organotechnetium Compounds".
This graph shows the total number of publications written about "Organotechnetium Compounds" by people in this website by year, and whether "Organotechnetium Compounds" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 2 | 0 | 2 |
| 1997 | 1 | 0 | 1 |
| 1998 | 1 | 0 | 1 |
| 2000 | 5 | 1 | 6 |
| 2002 | 1 | 0 | 1 |
| 2007 | 0 | 1 | 1 |
| 2008 | 1 | 0 | 1 |
| 2009 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Organotechnetium Compounds" by people in Profiles.
-
Hopkins LO, Feyssa E, Parsikia A, Khanmoradi K, Zaki R, Campos S, Araya V, Tran H, Ortiz J. Tc-99m-BrIDA hepatobiliary (HIDA) scan has a low sensitivity for detecting biliary complications after orthotopic liver transplantation in patients with hyperbilirubinemia. Ann Nucl Med. 2011 Dec; 25(10):762-7.
-
Penn DL, Kim C, Zhang K, Mukherjee A, Devakumar D, Jungkind D, Thakur ML. Apoptotic abscess imaging with 99mTc-HYNIC-rh-Annexin-V. Nucl Med Biol. 2010 Jan; 37(1):29-34.
-
Kurihara H, Yang DJ, Cristofanilli M, Erwin WD, Yu DF, Kohanim S, Mendez R, Kim EE. Imaging and dosimetry of 99mTc EC annexin V: preliminary clinical study targeting apoptosis in breast tumors. Appl Radiat Isot. 2008 Sep; 66(9):1175-82.
-
Zhang K, Aruva MR, Shanthly N, Cardi CA, Rattan S, Patel C, Kim C, McCue PA, Wickstrom E, Thakur ML. PET imaging of VPAC1 expression in experimental and spontaneous prostate cancer. J Nucl Med. 2008 Jan; 49(1):112-21.
-
Wolfe HR, Mendizabal M, Lleong E, Cuthbertson A, Desai V, Pullan S, Fujii DK, Morrison M, Pither R, Waldman SA. In vivo imaging of human colon cancer xenografts in immunodeficient mice using a guanylyl cyclase C--specific ligand. J Nucl Med. 2002 Mar; 43(3):392-9.
-
Rao PS, Pallela VR, Vassileva-Belnikolovska D, Jungkind D, Thakur ML. A receptor-specific peptide for imaging infection and inflammation. Nucl Med Commun. 2000 Nov; 21(11):1063-70.
-
Jovin TG, Vitti RA, McCluskey LF. Evolution of temporal lobe hypoperfusion in transient global amnesia: a serial single photon emission computed tomography study. J Neuroimaging. 2000 Oct; 10(4):238-41.
-
Klem JA, Schaffer JV, Crane PD, Barrett JA, Henry GA, Canestri L, Ezekowitz MD. Detection of deep venous thrombosis by DMP 444, a platelet IIb/IIIa antagonist: a preliminary report. J Nucl Cardiol. 2000 Jul-Aug; 7(4):359-64.
-
Wegener WA, Petrelli N, Serafini A, Goldenberg DM. Safety and efficacy of arcitumomab imaging in colorectal cancer after repeated administration. J Nucl Med. 2000 Jun; 41(6):1016-20.
-
Thakur ML, Pallela VR, Consigny PM, Rao PS, Vessileva-Belnikolovska D, Shi R. Imaging vascular thrombosis with 99mTc-labeled fibrin alpha-chain peptide. J Nucl Med. 2000 Jan; 41(1):161-8.